https://niho.sk/projekty/brigatinib-alunbrig-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:24:40+01:00https://niho.sk/projekty/alfaoktokog-advate-hodnotenie-podla-zakona-c-358-2021-z-z/2024-09-11T09:02:54+02:00https://niho.sk/projekty/daratumumab-darzalex-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:20:55+01:00https://niho.sk/projekty/rizankizumab-skyrizi-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:25:45+01:00https://niho.sk/projekty/benralizumab-fasenra-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:29:33+01:00https://niho.sk/projekty/tucatinib-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-11T15:34:24+01:00https://niho.sk/projekty/inklisiran-leqvio-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:26:42+01:00https://niho.sk/projekty/darolutamid-nubeqa-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:26:01+01:00https://niho.sk/projekty/esketamin-spravato-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-10T13:48:03+01:00https://niho.sk/projekty/opdivo-indikacia-melanom/2025-02-07T14:31:59+01:00https://niho.sk/projekty/nivolumab-opdivo-indikacia-karcinom-z-renalnych-buniek-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:32:42+01:00https://niho.sk/projekty/finerenon-kerendia-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:24:54+01:00https://niho.sk/projekty/abrocitinib-cibinqo-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:27:09+01:00https://niho.sk/projekty/palbociklib-ibrance-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:33:18+01:00https://niho.sk/projekty/ribociklib-kisqali-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:31:04+01:00https://niho.sk/projekty/enzalutamid-xtandi-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:35:39+01:00https://niho.sk/projekty/tafamidis-vyndaqel-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:34:16+01:00https://niho.sk/projekty/dabrafenib-tafinlar-trametinib-mekinist-hodnotenie-podla-zakona-c-358-2021-z-z/2025-02-07T14:34:50+01:00https://niho.sk/projekty/nintedanib-ofev-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:37:49+01:00https://niho.sk/projekty/abemaciklib-verzenios-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:46:02+01:00https://niho.sk/projekty/tisagenlekleucel-kymriah-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:43:34+01:00https://niho.sk/projekty/sofosbuvir-a-velpatasvir-epclusa-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:29:57+01:00https://niho.sk/projekty/andexanet-alfa-ondexxya-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:36:23+01:00https://niho.sk/projekty/emicizumab-hemlibra-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:37:09+01:00https://niho.sk/projekty/tixagevimab-a-cilgavimab-evusheld-%e2%88%92-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:38:13+01:00https://niho.sk/projekty/atezolizumab-tecentriq-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:37:30+01:00https://niho.sk/projekty/axikabtagen-ciloleucel-yescarta-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-07T14:38:36+01:00https://niho.sk/projekty/polatuzumab-vedotin-polivy-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:40:57+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:39:31+01:00https://niho.sk/projekty/atezolizumab-tecentriq-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:36:17+01:00https://niho.sk/projekty/trastuzumab-deruxtekan-enhertu-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:40:26+01:00https://niho.sk/projekty/onasemnogen-abeparvovek-zolgensma-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:39:04+01:00https://niho.sk/projekty/olaparib-lynparza-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:42:28+01:00https://niho.sk/projekty/rimegepant-vydura-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:41:23+01:00https://niho.sk/projekty/osimertinib-tagrisso-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:46:48+01:00https://niho.sk/projekty/ibrutinib-imbruvica-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:43:04+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:39:57+01:00https://niho.sk/projekty/kanabidiol-epidyolex-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:49:04+01:00https://niho.sk/projekty/sotorasib-lumykras-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:47:18+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022-2/2025-02-10T13:51:01+01:00https://niho.sk/projekty/daratumumab-darzalex-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:55:05+01:00https://niho.sk/projekty/ivakaftor-tezakaftor-a-elexakaftor-kaftrio-a-ivakaftor-kalydeco-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platn/2024-09-11T09:10:29+02:00https://niho.sk/projekty/brexukabtagen-autoleucel-tecartus-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-do-31-7-2022-aktualizacia-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:52:38+01:00https://niho.sk/projekty/ekulizumab-soliris-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:54:29+01:00https://niho.sk/projekty/hemlibra-emicizumab-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T13:51:55+01:00https://niho.sk/projekty/tebentafusp-kimmtrak-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:11:10+01:00https://niho.sk/projekty/darolutamid-nubeqa-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:04:52+01:00https://niho.sk/projekty/maribavir-livtencity-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:06:26+01:00https://niho.sk/projekty/brentuximab-vedotin-adcetris-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-01-22T14:37:34+01:00https://niho.sk/projekty/nirmatrelvir-a-ritonavir-paxlovid-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:06:56+01:00https://niho.sk/projekty/efgartigimod-alfa-vyvgart-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:11:41+01:00https://niho.sk/projekty/kyselina-obeticholova-ocaliva-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022/2025-02-10T14:07:50+01:00https://niho.sk/projekty/analyza-dopadu-na-rozpocet-zmeny-indikacneho-obmedzenia-lieciva-infliximab-so-subkutannou-formou-podania/2025-02-10T13:53:46+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2023/2025-02-10T14:09:44+01:00https://niho.sk/projekty/brukinsa-zanubrutinib-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2023/2025-02-10T14:24:54+01:00https://niho.sk/projekty/upadacitinib-rinvoq-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2022/2025-02-10T14:22:02+01:00https://niho.sk/projekty/sacituzumab-govitekan-trodelvy-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2023/2025-02-10T14:08:59+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2022/2025-02-10T14:22:37+01:00https://niho.sk/projekty/empagliflozin-jardiance-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2022/2025-02-10T14:23:10+01:00https://niho.sk/projekty/nivolumab-opdivo-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2023/2025-02-10T14:23:50+01:00https://niho.sk/projekty/lonkastuximab-tesirin-zynlonta-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:26:37+01:00https://niho.sk/projekty/talkvetamab-talvey-hodnotenie-podla-zakona-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:27:41+01:00https://niho.sk/projekty/bimekizumab-bimzelx-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-03-24T11:00:29+01:00https://niho.sk/projekty/selumetinib-koselugo-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-11T15:14:45+01:00https://niho.sk/projekty/ruxolitinib-jakavi-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:25:54+01:00https://niho.sk/projekty/sekukinumab-cosentyx-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:26:01+01:00https://niho.sk/projekty/inklisiran-leqvio-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:27:03+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:30:29+01:00https://niho.sk/projekty/tirzepatid-mounjaro-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:26:58+01:00https://niho.sk/projekty/vutrisiran-amvuttra-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-11T15:33:15+01:00https://niho.sk/projekty/osimertinib-tagrisso-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-10T14:31:36+01:00https://niho.sk/projekty/acikabtagen-ciloleucel-yescarta-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-11T15:15:15+01:00https://niho.sk/projekty/kabozantinib-cabometyx-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-11T15:15:41+01:00https://niho.sk/projekty/kaftrio-ivakaftor-tezakaftor-elexakaftor-kalydeco-ivakaftor-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:48:19+01:00https://niho.sk/projekty/olaparib-lynparza-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022-2/2025-02-12T09:33:57+01:00https://niho.sk/projekty/trifluridin-a-tipiracil-lonsurf-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:28:10+01:00https://niho.sk/projekty/pembrolizumab-keytruda-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024-2/2025-02-12T09:28:47+01:00https://niho.sk/projekty/ritlecitinib-litfulo-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:27:40+01:00https://niho.sk/projekty/imlifidaza-idefirix-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-11T15:16:50+01:00https://niho.sk/projekty/elranatamab-elrexfio-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:31:08+01:00https://niho.sk/projekty/talazoparib-talzenna-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:36:16+01:00https://niho.sk/projekty/glofitamab-columvi-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-1-2024/2025-02-12T09:41:37+01:00https://niho.sk/projekty/ipilimumab-yervoy-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2024/2025-02-12T09:38:39+01:00https://niho.sk/projekty/cemiplimab-libtayo-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2024/2025-07-08T16:49:47+02:00https://niho.sk/projekty/2122/2025-02-12T09:34:44+01:00https://niho.sk/projekty/dapagliflozin-forxiga-hodnotenie-podla-zakona-c-358-2021-z-z-ucinneho-od-1-8-2024/2025-04-29T17:10:29+02:00https://niho.sk/projekty/ockovacia-latka-proti-respiracnemu-syncycialnemu-virusu-rsv-stabilizovany-predfuzny-f-antigen-abrysvo/2025-02-12T10:13:44+01:00https://niho.sk/projekty/skilarence-dimetyl-fumarat/2024-09-23T14:19:52+02:00https://niho.sk/projekty/asciminib-scemblix/2024-10-18T10:36:04+02:00https://niho.sk/projekty/okrelizumab-ocrevus/2024-10-04T14:42:01+02:00https://niho.sk/projekty/vozoritid-voxzogo/2025-02-12T11:17:54+01:00https://niho.sk/projekty/akalabrutinib-calquence/2025-02-18T15:53:18+01:00https://niho.sk/projekty/tofacitinib-xeljanz/2024-12-19T17:48:04+01:00https://niho.sk/projekty/brodalumab-kyntheum/2024-11-27T13:02:33+01:00https://niho.sk/projekty/atogepant-aquipta/2024-10-23T13:49:43+02:00https://niho.sk/projekty/fludrokortizon-zonta/2024-09-20T13:33:12+02:00https://niho.sk/projekty/folitropin-delta-rekovelle/2025-04-16T11:51:55+02:00https://niho.sk/projekty/glykopyronium-sialanar/2024-12-20T11:33:38+01:00https://niho.sk/projekty/finerenon-kerendia/2024-10-11T11:24:35+02:00https://niho.sk/projekty/ockovacia-latka-proti-respiracnemu-syncycialnemu-virusu-stabilizovany-predfuzny-f-antigen-abrysvo/2024-12-11T15:42:53+01:00https://niho.sk/projekty/mavakamten-camzyos/2025-02-12T11:17:17+01:00https://niho.sk/projekty/mirikizumab-omvoh/2024-12-19T09:06:59+01:00https://niho.sk/projekty/niraparib-a-abirateron-acetat-akeega/2024-12-19T17:48:41+01:00https://niho.sk/projekty/siltuximab-sylvant/2025-01-10T17:07:38+01:00https://niho.sk/projekty/vitamin-b12-leciva/2024-11-15T13:41:14+01:00https://niho.sk/projekty/tildrakizumab-ilumetri/2024-11-15T13:40:59+01:00https://niho.sk/projekty/naproxen-a-ezomeprazol-emoxen-plus/2024-11-15T13:40:37+01:00https://niho.sk/projekty/aripiprazol-ablify-maintena/2024-11-15T13:39:47+01:00https://niho.sk/projekty/avapritinib-ayvakyt/2024-10-24T14:05:09+02:00https://niho.sk/projekty/formoterol-a-glykopyronium-bromid-bevespi-aerosphere/2025-01-22T09:36:40+01:00https://niho.sk/projekty/formoterol-glykopyronium-bromid-a-budezonid-trixeo-aerosphere/2024-12-17T09:47:24+01:00https://niho.sk/projekty/pembrolizumab-keytruda/2025-01-23T15:31:54+01:00https://niho.sk/projekty/osilodrostat-isturisa/2025-02-24T16:30:41+01:00https://niho.sk/projekty/kabazitaxel-cabazitaxel-ever-pharma/2025-01-20T14:24:44+01:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-1-10-2024/2025-01-31T10:38:55+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-25-09-2024/2025-01-31T10:38:40+01:00https://niho.sk/projekty/specialny-zdravotnicky-material-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-26-09-2024/2025-01-31T10:38:21+01:00https://niho.sk/projekty/pegunigalzidaza-alfa-elfabrio/2025-03-07T11:45:32+01:00https://niho.sk/projekty/anifrolumab-saphnelo/2025-03-21T09:49:58+01:00https://niho.sk/projekty/krytia-na-rany-urgostart/2025-08-27T15:03:30+02:00https://niho.sk/projekty/voklosporin-lupkynis/2024-12-19T13:39:35+01:00https://niho.sk/projekty/iptakopan-fabhalta/2025-03-24T10:57:08+01:00https://niho.sk/projekty/nacuvacie-pristroje-signia/2024-11-29T18:22:30+01:00https://niho.sk/projekty/suprava-infuzna-subkutanna-flowease/2024-12-09T16:30:13+01:00https://niho.sk/projekty/hydrokortizon-alkindi/2024-12-17T16:17:12+01:00https://niho.sk/projekty/gel-na-rany-hyiodine/2024-12-20T14:20:16+01:00https://niho.sk/projekty/ivozidenib-tibsovo/2025-04-09T13:59:35+02:00https://niho.sk/projekty/foslevodopa-foskarbidopa-duodopa-sc/2025-01-31T16:13:31+01:00https://niho.sk/projekty/endoproteza-kolena-attune/2024-11-28T15:17:00+01:00https://niho.sk/projekty/system-na-trombektomiu-neva-net/2024-11-28T15:15:32+01:00https://niho.sk/projekty/chlopna-edwards-sapien-3-ultra-resilia/2025-03-07T18:47:30+01:00https://niho.sk/projekty/krytie-na-rany-cutimed/2025-03-11T20:31:19+01:00https://niho.sk/projekty/inzulinove-pero-inpen/2025-02-07T19:58:51+01:00https://niho.sk/projekty/krytie-leukomed-control/2025-06-02T20:53:32+02:00https://niho.sk/projekty/system-na-trombektomiu-envast/2025-02-10T16:16:28+01:00https://niho.sk/projekty/ketoanalog/2025-03-07T18:44:53+01:00https://niho.sk/projekty/shunt-hero-graft-s-prislusenstvom-revizne-prislusenstvo/2024-12-13T19:26:55+01:00https://niho.sk/projekty/berotralstat-orladeyo/2025-01-10T15:39:13+01:00https://niho.sk/projekty/fedratinib-inrebic/2026-03-05T10:35:19+01:00https://niho.sk/projekty/pembrolizumab-keytruda-2/2025-03-24T10:58:05+01:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-3-12-2024/2025-01-31T10:37:56+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-4-12-2024/2025-01-31T10:37:38+01:00https://niho.sk/projekty/specialny-zdravotnicky-material-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-5-12-2024/2025-01-31T10:37:13+01:00https://niho.sk/projekty/maralixibat-livmarli/2025-05-05T12:50:00+02:00https://niho.sk/projekty/erenumab-aimovig/2025-02-05T15:24:31+01:00https://niho.sk/projekty/omaveloxolon-skyclarys/2025-03-24T11:01:09+01:00https://niho.sk/projekty/tisagenlekleucel-kymriah/2025-03-24T10:56:25+01:00https://niho.sk/projekty/rozanolixizumab-rystiggo/2025-03-24T10:57:42+01:00https://niho.sk/projekty/efanesoktokog-alfa-altuvoct/2025-05-30T15:40:26+02:00https://niho.sk/projekty/zanubrutinib-brukinsa/2025-04-17T09:49:18+02:00https://niho.sk/projekty/zanubrutinib-brukinsa-2/2025-04-17T09:52:21+02:00https://niho.sk/projekty/pertuzumab-a-trastuzumab-phesgo/2025-05-02T14:55:55+02:00https://niho.sk/projekty/daratumumab-darzalex/2025-03-24T15:44:34+01:00https://niho.sk/projekty/givosiran-givlaari/2025-04-28T14:18:50+02:00https://niho.sk/projekty/karfilzomib-kyprolis/2025-05-22T14:05:18+02:00https://niho.sk/projekty/rimegepant-vydura/2025-06-10T11:24:08+02:00https://niho.sk/projekty/kapmatinib-tabrecta/2025-04-17T12:31:16+02:00https://niho.sk/projekty/atezolizumab-tecentriq/2025-03-25T14:55:12+01:00https://niho.sk/projekty/mepolizumab-nucala/2025-06-06T15:40:46+02:00https://niho.sk/projekty/atezolizumab-tecentriq-2/2025-03-25T14:54:48+01:00https://niho.sk/projekty/bezzvodovy-jednodutinovy-kardiostimulator-aveir/2025-06-09T22:00:48+02:00https://niho.sk/projekty/srdcova-chlopna-navitor-vision-technology/2025-03-07T18:46:09+01:00https://niho.sk/projekty/kateter-na-meranie-intrakranialneho-tlaku-teploty-a-kyslika-neurovent-pto-a-neurovent-pto-2l/2025-09-04T16:56:39+02:00https://niho.sk/projekty/aplikacne-pero-ever-pharma-d-mine/2025-10-22T15:54:12+02:00https://niho.sk/projekty/idebenon-raxone/2025-03-19T11:22:42+01:00https://niho.sk/projekty/ravulizumab-ultomiris/2025-06-25T16:03:06+02:00https://niho.sk/projekty/rizankizumab-skyrizi/2025-06-27T15:06:40+02:00https://niho.sk/projekty/enkorafenib-braftovi/2025-03-17T16:42:17+01:00https://niho.sk/projekty/dabrafenib-tafinlar-trametinib-mekinist/2025-07-04T18:13:40+02:00https://niho.sk/projekty/mexiletin-namuscla/2025-04-30T16:07:16+02:00https://niho.sk/projekty/karfilzomib-kyprolis-2/2025-06-26T14:23:43+02:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-11-3-2025/2025-03-10T16:45:22+01:00https://niho.sk/projekty/lizdexamfetamindiium-dimezylat-livizux/2025-04-02T16:43:25+02:00https://niho.sk/projekty/ofatumumab-kesimpta/2025-03-24T13:34:24+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-11-3-2025/2025-03-12T16:32:44+01:00https://niho.sk/projekty/telmisartan-a-indapamid-ylpio/2025-03-27T15:31:16+01:00https://niho.sk/projekty/kanagliflozin-invokana/2025-03-27T15:30:43+01:00https://niho.sk/projekty/specialne-zdravotnicke-materialy-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-13-3-2025/2025-03-12T16:28:54+01:00https://niho.sk/projekty/zilukoplan-zilbrysq/2025-06-13T16:09:08+02:00https://niho.sk/projekty/inebilizumab-uplizna/2025-06-06T14:05:37+02:00https://niho.sk/projekty/ravulizumab-ultomiris-2/2025-06-03T16:35:53+02:00https://niho.sk/projekty/mobiderm-intimate-short-damske-a-panske/2025-05-09T20:40:12+02:00https://niho.sk/projekty/system-na-endoskopicke-sitie-overstitch-overstitch-sx-overstitch-nxt-s-prislusenstvom/2025-08-14T16:54:36+02:00https://niho.sk/projekty/system-venusp-valve/2025-08-28T17:29:53+02:00https://niho.sk/projekty/sotatercept-winrevair/2025-09-23T17:14:20+02:00https://niho.sk/projekty/20-valentna-pneumokokova-konjugovana-vakcina-prevenar-20/2025-08-07T13:30:32+02:00https://niho.sk/projekty/trastuzumab-deruxtekan-enhertu/2025-11-25T14:32:45+01:00https://niho.sk/projekty/faricimab-vabysmo/2025-05-13T14:58:58+02:00https://niho.sk/projekty/tepotinib-tepmetko/2025-07-11T16:20:37+02:00https://niho.sk/projekty/elranatamab-elrexfio/2025-08-20T14:28:45+02:00https://niho.sk/projekty/alecensa-alektinib/2025-04-29T11:53:31+02:00https://niho.sk/projekty/lebrikizumab-ebglyss/2025-04-29T17:06:41+02:00https://niho.sk/projekty/skilarence-dimetyl-fumarat-2/2025-06-13T15:44:23+02:00https://niho.sk/projekty/bimekizumab-bimzelx/2025-10-28T15:57:52+01:00https://niho.sk/projekty/aripiprazol-abilify-maintena/2025-04-24T15:28:21+02:00https://niho.sk/projekty/standardizovany-extrakt-alergenu-staloral/2025-04-24T15:32:35+02:00https://niho.sk/projekty/gadopiklenol-vueway/2025-08-01T18:34:16+02:00https://niho.sk/projekty/endoskopicky-prichytavaci-system-x-tack/2025-05-30T17:38:53+02:00https://niho.sk/projekty/krytie-na-rany-cutimed-sorbact-pad/2025-05-07T21:51:47+02:00https://niho.sk/projekty/chlopna-harmony-tpv-system/2025-09-11T15:40:23+02:00https://niho.sk/projekty/humanny-menopauzalny-gonadotropin-meriofert-kit-900-iu/2025-06-09T16:07:23+02:00https://niho.sk/projekty/ludsky-von-willebrandov-faktor-a-ludsky-koagulacny-faktor-viii-wilate/2025-06-16T15:18:00+02:00https://niho.sk/projekty/larotrektinib-vitrakvi/2025-05-15T16:07:41+02:00https://niho.sk/projekty/atezolizumab-tecentriq-3/2025-10-02T17:06:25+02:00https://niho.sk/projekty/akoramidis-beyonttra/2025-10-01T15:36:52+02:00https://niho.sk/projekty/tofersen-qalsody/2025-07-29T08:10:55+02:00https://niho.sk/projekty/frukvintinib-fruzaqla/2025-10-01T16:36:58+02:00https://niho.sk/projekty/empaglifozin-jardiance/2025-09-11T15:46:52+02:00https://niho.sk/projekty/ribociklib-kisqali/2025-10-21T16:50:35+02:00https://niho.sk/projekty/doplnkova-vyziva-tylactin-build/2025-08-11T22:15:51+02:00https://niho.sk/projekty/roztok-kyseliny-hyaluronovej-intraartikularny-sinovial-hl-32/2025-08-28T17:28:23+02:00https://niho.sk/projekty/system-intragastrickeho-balonika-orbera365/2025-09-16T14:37:21+02:00https://niho.sk/projekty/system-istent-inject/2026-03-04T11:43:51+01:00https://niho.sk/projekty/mobiderm-intimate-bra/2025-10-20T17:20:14+02:00https://niho.sk/projekty/nivolumab-opdivo/2025-10-06T14:47:41+02:00https://niho.sk/projekty/kabozantinib-cabometyx/2026-03-20T13:22:12+01:00https://niho.sk/projekty/kabozantinib-cabometyx-2/2026-03-20T13:20:38+01:00https://niho.sk/projekty/specialne-zdravotnicke-materialy-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-12-6-2025/2025-06-11T17:10:49+02:00https://niho.sk/projekty/krytie-na-rany-cutimed-sorbact-pad-10x20-cm/2025-06-11T17:20:06+02:00https://niho.sk/projekty/durvalumab-imfinzi/2025-09-10T16:03:08+02:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-3-6-2025/2025-06-13T15:40:32+02:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-17-6-2025/2025-06-16T16:56:52+02:00https://niho.sk/projekty/pembrolizumab-keytruda-3/2025-10-06T14:53:24+02:00https://niho.sk/projekty/klietka-twin-peaks/2025-10-20T16:54:39+02:00https://niho.sk/projekty/system-aspiracny-indigo-cat-rx/2025-09-05T15:02:39+02:00https://niho.sk/projekty/dostarlimab-jemperli/2025-11-27T17:01:13+01:00https://niho.sk/projekty/pemigatinib-pemazyre/2025-09-23T13:13:13+02:00https://niho.sk/projekty/otocna-svorka-mantis/2025-10-22T15:49:45+02:00https://niho.sk/projekty/ripretinib-qinlock/2025-12-15T16:51:58+01:00https://niho.sk/projekty/blinatumomab-blincyto/2025-11-12T15:34:20+01:00https://niho.sk/projekty/trametinib-spexotras-dabrafenib-finlee/2025-12-12T16:03:53+01:00https://niho.sk/projekty/pku-sphere15/2025-11-07T16:31:06+01:00https://niho.sk/projekty/krem-hydrogel-prasok-a-sprej-na-rany-vulnamin/2025-12-04T16:55:57+01:00https://niho.sk/projekty/flutikazon-a-formoterol-flutiform/2025-11-17T12:53:55+01:00https://niho.sk/projekty/system-stentgraftu-beflared-fevar/2025-09-09T15:34:14+02:00https://niho.sk/projekty/olaparib-lynparza/2026-03-10T17:03:58+01:00https://niho.sk/projekty/ropeginterferon-alfa-2b-besremi/2026-03-10T15:50:26+01:00https://niho.sk/projekty/relugolix-orgovyx/2025-11-06T15:01:14+01:00https://niho.sk/projekty/suprava-extrakcna-bib/2025-10-27T16:29:29+01:00https://niho.sk/projekty/system-intragastricky-balonikovy-bib/2025-10-27T16:28:14+01:00https://niho.sk/projekty/enfortumab-vedotin-padcev/2026-02-24T16:28:38+01:00https://niho.sk/projekty/enfortumab-vedotin-padcev-2/2026-02-24T16:33:50+01:00https://niho.sk/projekty/doplnok-vyzivy-glutam-ther/2025-11-05T15:57:34+01:00https://niho.sk/projekty/ciltakabtagen-autoleucel-carvykti/2026-02-10T16:04:13+01:00https://niho.sk/projekty/karoticky-stent-caresto-heal/2026-01-21T14:13:57+01:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-23-9-2025/2025-09-23T21:58:18+02:00https://niho.sk/projekty/guselkumab-tremfya/2026-03-20T20:57:58+01:00https://niho.sk/projekty/guselkumab-tremfya-2/2025-11-06T14:55:45+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-ku-kk-dna-24-9-2025/2025-09-23T21:57:11+02:00https://niho.sk/projekty/specialne-zdravotnicke-materialy-ziadosti-o-zaradenie-do-existujucej-podskupiny/2025-10-13T16:35:25+02:00https://niho.sk/projekty/bulevirtid-hepcludex/2026-02-19T15:34:56+01:00https://niho.sk/projekty/nivolumab-relatlimab-opdualag/2025-12-19T17:19:05+01:00https://niho.sk/projekty/system-zavadzaci-intrakranialny-benchmark/2025-12-04T14:16:00+01:00https://niho.sk/projekty/daratumumab-darzalex-2/2026-03-31T16:58:57+02:00https://niho.sk/projekty/luspatercept-reblozyl/2025-10-09T17:12:10+02:00https://niho.sk/projekty/avakopan-tavneos/2025-10-17T10:00:57+02:00https://niho.sk/projekty/elafibranor-iqirvo/2026-01-23T13:25:22+01:00https://niho.sk/projekty/amivantamab-rybrevant-lazertinib-lazcluze/2026-02-04T17:34:15+01:00https://niho.sk/projekty/olaparib-lynparza-2/2026-02-26T16:07:12+01:00https://niho.sk/projekty/aortalna-chlopna-evolut-fx/2025-12-19T14:44:07+01:00https://niho.sk/projekty/system-koronarneho-bioadaptera-dynamx/2026-01-15T14:35:03+01:00https://niho.sk/projekty/orteza-bedroveho-klbu-hip-rush/2025-12-19T20:11:49+01:00https://niho.sk/projekty/doplnkova-vyziva-tyr-sphere-20/2025-11-27T13:38:08+01:00https://niho.sk/projekty/durvalumab-imfinzi-2/2026-03-25T15:37:16+01:00https://niho.sk/projekty/tafasitamab-minjuvi/2026-02-26T16:01:31+01:00https://niho.sk/projekty/oznamenie-o-zacati-hodnotenia-dietetickych-potravin-ktore-su-predmetom-ziadosti-o-zaradenie-do-existujucej-podskupiny/2025-11-18T16:25:13+01:00https://niho.sk/projekty/serplulimab-hetronifly/2025-11-05T12:33:22+01:00https://niho.sk/projekty/bandaz-sternalna-podporna-posthorax-pro/2026-04-01T16:01:12+02:00https://niho.sk/projekty/mirikizumab-omvoh-2/2025-12-17T16:53:19+01:00https://niho.sk/projekty/cipaglukozidaza-alfa-pombiliti-miglustat-opfolda/2026-04-02T13:39:37+02:00https://niho.sk/projekty/darolutamid-nubeqa/2025-11-11T16:51:43+01:00https://niho.sk/projekty/cemiplimab-libtayo/2025-11-13T18:40:06+01:00https://niho.sk/projekty/pneumokokova-polysacharidova-konjugovana-ockovacia-latka-21-valentna-capvaxive/2025-11-14T18:48:37+01:00https://niho.sk/projekty/seladelpar-lyvdelzi/2026-02-02T15:09:50+01:00https://niho.sk/projekty/pembrolizumab-keytruda-4/2026-03-26T14:46:01+01:00https://niho.sk/projekty/oznamenie-o-zacati-hodnotenia-zdravotnickych-pomocok-ktore-su-predmetom-ziadosti-o-zaradenie-do-existujucej-podskupiny-2/2025-12-09T15:52:22+01:00https://niho.sk/projekty/oznamenie-o-zacati-hodnotenia-specialnych-zdravotnickych-materialov-ktore-su-predmetom-ziadosti-o-zaradenie-do-existujucej-podskupiny/2025-12-10T15:10:05+01:00https://niho.sk/projekty/tirzepatid-mounjaro/2026-01-14T21:22:14+01:00https://niho.sk/projekty/ihla-koaxialna-zavadzacia/2025-12-03T17:23:37+01:00https://niho.sk/projekty/elektrody-na-aplikaciu-intravezikalnej-elektroterapie/2026-04-01T16:05:39+02:00https://niho.sk/projekty/system-aspiracny-indigo-cat-rx-2/2026-02-24T16:04:00+01:00https://niho.sk/projekty/durvalumab-imfinzi-3/2026-02-27T10:28:08+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny/2025-12-09T15:55:19+01:00https://niho.sk/projekty/specialne-zdravotnicke-materialy-ziadosti-o-zaradenie-do-existujucej-podskupiny-2/2025-12-10T15:12:05+01:00https://niho.sk/projekty/radamts13-adzynma/2026-03-03T14:12:07+01:00https://niho.sk/projekty/rozsirenie-preskripcneho-obmedzenia-podskupiny-xb6-16/2026-02-10T15:37:19+01:00https://niho.sk/projekty/zariadenie-na-liecbu-vazospazmu-prelax/2026-01-29T16:35:11+01:00https://niho.sk/projekty/teleskop-implantovatelny-miniaturny-sing-imt/2026-02-27T14:18:05+01:00https://niho.sk/projekty/chodulka-4-kolesova-jl965lht/2026-02-10T15:29:55+01:00https://niho.sk/projekty/recovy-procesor-sonnet-3-a-rondo-3/2026-01-26T16:53:12+01:00https://niho.sk/projekty/extrakt-z-brezy-filsuvez/2026-02-26T16:11:15+01:00https://niho.sk/projekty/obuv-zdravotna-specialna-profylakticka-pre-diabetikov/2026-02-03T16:50:12+01:00https://niho.sk/projekty/pirtobrutinib-jaypirca/2026-02-11T13:46:04+01:00https://niho.sk/projekty/system-monitorovania-glukozy-freestyle-libre-2-plus/2026-02-27T12:30:52+01:00https://niho.sk/projekty/pirtobrutinib-jaypirca-2/2026-02-12T15:12:36+01:00https://niho.sk/projekty/imbruvica-ibrutinib/2026-02-12T15:16:49+01:00https://niho.sk/projekty/krytie-na-rany-cutimed-sorbact-hydro/2026-02-13T08:18:10+01:00https://niho.sk/projekty/sugemalimab-cejemly/2026-02-13T08:42:52+01:00https://niho.sk/projekty/hcu-anamix-infant/2026-02-18T14:45:40+01:00https://niho.sk/projekty/msud-anamix-infant/2026-02-18T14:48:47+01:00https://niho.sk/projekty/tezepelumab-tezspire/2026-02-18T14:55:48+01:00https://niho.sk/projekty/oznamenie-o-zacati-hodnotenia-specialnych-zdravotnickych-materialov-ktore-su-predmetom-ziadosti-o-zaradenie-do-existujucej-podskupiny-2/2026-03-10T17:11:10+01:00https://niho.sk/projekty/oznamenie-o-zacati-hodnotenia-zdravotnickych-pomocok-ktore-su-predmetom-ziadosti-o-zaradenie-do-existujucej-podskupiny/2026-03-09T13:51:33+01:00https://niho.sk/projekty/benralizumab-fasenra/2026-02-23T16:44:43+01:00https://niho.sk/projekty/duocal/2026-04-24T16:07:09+02:00https://niho.sk/projekty/tegomil-fumarat-riulvy/2026-04-02T16:44:48+02:00https://niho.sk/projekty/akalabrutinib-calquence-2/2026-02-25T16:01:38+01:00https://niho.sk/projekty/brentuximab-vedotin-adcetris/2026-02-27T11:23:10+01:00https://niho.sk/projekty/cholesterol-module/2026-02-27T12:35:56+01:00https://niho.sk/projekty/korifolitropin-alfa-elonva/2026-03-06T14:40:15+01:00https://niho.sk/projekty/dieteticke-potraviny-ziadosti-o-zaradenie-do-existujucej-podskupiny/2026-03-09T13:47:46+01:00https://niho.sk/projekty/zdravotnicke-pomocky-ziadosti-o-zaradenie-do-existujucej-podskupiny-2/2026-03-09T13:53:44+01:00https://niho.sk/projekty/ludsky-imunoglobulin-scig-cuvitru/2026-03-09T17:50:23+01:00https://niho.sk/projekty/midazolam-buccolam/2026-04-02T13:00:40+02:00https://niho.sk/projekty/specialne-zdravotnicke-materialy-ziadosti-o-zaradenie-do-existujucej-podskupiny-3/2026-03-11T20:42:51+01:00https://niho.sk/projekty/mirikizumab-omvoh-3/2026-03-10T17:08:29+01:00https://niho.sk/projekty/milupa-basic-cad/2026-03-10T17:15:50+01:00https://niho.sk/projekty/sonda-kryoablacna-cryoice/2026-03-10T17:16:48+01:00https://niho.sk/projekty/pembrolizumab-keytruda-5/2026-03-11T12:46:25+01:00https://niho.sk/projekty/galactomin-19/2026-04-24T15:59:03+02:00https://niho.sk/projekty/gto-oil/2026-04-24T16:18:51+02:00https://niho.sk/projekty/lorenzo-oil/2026-04-24T16:13:11+02:00https://niho.sk/projekty/milupa-basic-f/2026-04-24T16:03:03+02:00https://niho.sk/projekty/folitropin-beta-puregon/2026-03-19T15:46:26+01:00https://niho.sk/projekty/ganirelix-orgalutran/2026-03-19T15:45:10+01:00https://niho.sk/projekty/monogen/2026-04-24T16:21:01+02:00https://niho.sk/projekty/nipokalimab-imaavy/2026-03-24T15:16:11+01:00https://niho.sk/projekty/sosovka-isopure-serenity/2026-04-22T16:29:13+02:00https://niho.sk/projekty/palopegteriparatid-yorvipath/2026-03-31T17:05:59+02:00https://niho.sk/projekty/tagrisso-ozimertinib/2026-04-16T12:51:31+02:00https://niho.sk/projekty/okrelizumab-ocrevus-2/2026-04-01T16:11:34+02:00https://niho.sk/projekty/akalabrutinib-calquence-3/2026-04-02T10:45:46+02:00https://niho.sk/projekty/arteriovenozny-shunt-hero-graft/2026-04-09T14:54:11+02:00https://niho.sk/projekty/akalabrutinib-calquence-4/2026-04-10T17:28:24+02:00https://niho.sk/projekty/hcu-easy-microtabs-plus/2026-04-15T16:35:05+02:00https://niho.sk/projekty/mirvetuximab-soravtanzin-elahere/2026-04-16T16:15:08+02:00https://niho.sk/projekty/nebivolol-a-amlodipin-nesyrgy/2026-04-20T17:45:11+02:00https://niho.sk/projekty/durvalumab-imfinzi-4/2026-04-23T17:09:46+02:00